
Endovia Health Sciences fell 95.2% from $2.98 to $0.14, behind the S&P 500's +9.7%. Its worst day was Jul 27 (−78.0%), and its low came Oct 19 at $0.14.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Endovia Health Sciences shares rose 53.0%, while the S&P 500 rose 1.5%.
+53.0% · S&P 500 +1.5%
Endovia Health Sciences closed at its highest level of the year, 101.5% above where the year started.
+2.0% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
Endovia Health Sciences shares rose 53.4%, while the S&P 500 rose 0.1%.
+53.4% · S&P 500 +0.1%
EPS of $-3.24 was reported on $-365,206.00 revenue.
+2.3% · S&P 500 +0.2%
EPS of $-1.88 was reported on $4,224.00 revenue.
−4.6% · S&P 500 +0.2%
Endovia Health Sciences shares rose 71.0%, while the S&P 500 fell 0.7%.
+71.0%, on 125M shares, the year's heaviest volume · S&P 500 −0.7%
Endovia Health Sciences shares rose 263.8%, while the S&P 500 fell 0.5%.
+263.8%, the year's best day · S&P 500 −0.5%
Endovia Health Sciences shares fell 78.0%, while the S&P 500 rose 0.0%.
−78.0%, the year's worst day · S&P 500 0.0%
EPS of $-0.77 was reported on $0.00 revenue.
+3.6% · S&P 500 −0.8%
Endovia Health Sciences closed at its lowest level of the year, 95.5% below where the year started.
−7.5% · S&P 500 +0.4%
Where it ended: a close of $0.14 on Nov 19, 2026. Up next: Q3 2026 earnings on Dec 2, 2026.
Nothing in the past 12 months.
All EDVA analyst actionsNothing in the past 12 months.
All EDVA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EDVA and SPY from Benzinga historical bars. Not investment advice.